Castrate-resistant prostate cancer: the right targets and combinations

Author： Karakunnel Joyson   Dahut William  

Publisher： Future Medicine

ISSN： 1475-0708

Source： Therapy, Vol.5, Iss.1, 2008-01, pp. : 57-61

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Castrate-Resistant Prostate Cancer with Peritoneal Metastases Treated with Docetaxel-Based Chemotherapy

By  

Urologia Internationalis, Vol. 93, Iss. 1, 2013-11 ,pp. : 49-54

Karger

Access to resources Recommend Favorite

Sequencing of Cabazitaxel in Metastatic Castrate-Resistant Prostate Cancer: A Case Report

By  

Case Reports in Oncology, Vol. 5, Iss. 2, 2012-06 ,pp. : 320-324

Karger

Access to resources Recommend Favorite

Implementing newer agents for the management of CRPC

By  

BJU INTERNATIONAL, Vol. 115, Iss. 3, 2015-03 ,pp. : 364-372

John Wiley & Sons Inc

Access to resources Recommend Favorite

Establishment of primary patient‐derived xenografts of palliative TURP specimens to study castrate‐resistant prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 13, 2015-09 ,pp. : 1475-1483

John Wiley & Sons Inc

Access to resources Recommend Favorite

The effect of prior androgen synthesis inhibition on outcomes of subsequent therapy with docetaxel in patients with metastatic castrate‐resistant prostate cancer

By  

CANCER, Vol. 119, Iss. 20, 2013-10 ,pp. : 3636-3643

John Wiley & Sons Inc

Access to resources Recommend Favorite